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EXPERIMENTAL CONTROLS IN CLINICAL
DERMATOLOGIC INVESTIGATION *
DONALD M. PILLSBURY, M.D., MURRAY C. ZIMMERMAN, M.D., AND
G. DOUGLAS BALDRIDGE, M.D.
Investigation of the comparative effectiveness of different methods of treat-
ment of a particular disease of the skin is often a difficult undertaking. We have
become very conscious of the numerous possible sources of error in the pursuance
of adequate clinical dermatologic investigations in our own clinics, and keenly
appreciative of the deficiencies of certain of our studies in the past. It is proposed
in this report (a) to list certain specific difficulties which have arisen in the course
of such experiments, (b) to cite examples of some widely accepted methods of
treatment, the value of which has apparently never been determined conclu-
sively by planned experiments, and (c) to summarize briefly and criticize three
illustrative clinical investigations from this department.
Much has been said and written concerning the necessity for increased fa-
cilities for basic studies of the normal and disturbed physiology of the human
skin. It is probable that the skin is the most neglected organ of the human body
in terms of lack of support of fundamental studies of it. In connection with this
deserved emphasis upon the need for basic laboratory studies, it is perhaps not
amiss to point out a similar pressing need for planned clinical investigations, and
to emphasize that adequate clinical studies are often much more difficult to carry
to a conclusion than are many laboratory studies.
In a laboratory study in which animals are used, the subjects may ordinarily
be kept under conditions of excellent control, and such studies, if well planned,
usually offer one or more accurate means of measuring the results obtained. On
the other hand, in studies of the treatment of disease in man, controlled condi-
tions of treatment of the subject, and accurate standards of measurement of the
results may be exceedingly difficult to attain. Since the results of studies dealing
with the treatment of disease in man are more likely to find immediate applica-
tion by other physicians than are studies in animals, however, it is obvious that
the responsibility of the clinical investigator to plan his studies logically and
carry them out conclusively is fully as great as that of the laboratory scientist.
Published reports of new methods of treatment are ordinarily merely a record of
observations.
The difference between observation and experimentation may be sharply
drawn, but usually is not. An observation records a fact, a series of facts, a
sequence of events, a result. The result may be due to the passage of time, to a
method of therapy, to psychosomatic influences, or to some other factor in which
the investigator might be interested. The observation may or may not indicate
the cause of the result, which may include several factors.
* From the Department of Dermatology and Syphilology, School of Medicine (Dr.
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Aibritton (1) has strikingly and ingeniously summarized the various factors
which may produce a result, in Fig. 1. Reading of Albritton's monograph is a
stimulating experience, and analysis of reports of clinical experiments from one's
own department on the basis of his simply stated criteria is most revealing. It
will be found disturbingly apparent in the case of some clinical reports, that the
design of the experiment made a final conclusion impossible; in others, the pres-
ence of uncontrollable "associated agents" made the conclusions equivocal;
while, in all too few, the conclusions were valid.
The following are the chief requirements of a planned study designed to pro-
vide data from which conclusions may be drawn:
1. Problem: something to be evaluated
2. Standard apparatus to be used in the evaluation
3. Standard procedures to be used throughout the experiment
4. Standard interpretation of results
5. A standard against which to measure results (control)
Investigations of methods of treatment of diseases of the skin offer difficulties
common to any experimental study, and must be planned carefully if unproduc-
tive work and expense are to be avoided, and if the conclusions reached are to be
valid. The skin offers certain advantages for study in that it is easily observed.
In other respects, however, it offers formidable barriers to the performance of
controlled clinical experiments. Some of the difficulties which have been encoun-
tered in our own clinics are as follows:
(1) The difficulty of standardization of "associated agents". The human skin is
exposed to a wider variety of agents than any other organ of the body. In addition
to almost innumerable contactants having primary irritant or sensitizing capa-
cities, the skin is subjected to constantly changing thermal and actinic influences,
and to a variable subcutaneous bath of highly complex nature. These factors are
?
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FIG. 1. Possible causes of a result
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only partially controllable. The profound influence of environmental and other
factors is well stated by Sulzberger and Wolfe (2), as follows, "environmental
change and hospitalization exercise such remarkable beneficial effects that in
many dermatoses this change is one of the most effective of dermatologic weap-
ons." Our experience is in complete accord with this, and has led us to exercise
great caution in evaluating the result of almost any type of treatment for skin
diseases of unpredictable course, in patients who have just been removed from
their home environment to a hospital.
(2) Difficulties in. the standardization of measurements. Hopkins (3) has recently
discussed this problem. If a lesion of the skin disappears completely, the imme-
diate result, whatever the cause, is obvious. In many diseases, however, the
extent of partial improvement of the lesions is difficult to measure, and a wide
variation in the "percentage of improvement" may be estimated on the same
patient by different observers. In determining changes in subjective symptoms,
particularly itching, the measurement is subject to great inaccuracies.
(3) Lack of accurate knowledge of the normal course of the disease under treatment.
It is obviously impossible to determine the effectiveness of a particular method
of treatment unless something is known of the course of the disease without treat-
ment, or under placebo therapy, is known. In the case of some diseases, e.g.,
psoriasis and lupus vulgaris, it is known that few patients recover. In other dis-
eases, e.g., atopic dermatitis, the course of the disease is extraordinarily erratic,
and collection of a "control" series of sufficient size to determine the effects of
associated agents and of chance, is extremely difficult. Even in the case of dis-
eases presumed to have a well-established simple cause, e.g., impetigo or scabies,
great variations in symptoms, severity, and extent may be noted. Acne, an
almost physiologic condition, disappears in most individuals, but in what per-
centage of them, and at what ages, is not definitely known.
(4) The enthusiasm of the individual investigator. Examples of this as a source
of error in clinical investigations are numerous. Without the quality of enthusi-
asm in the investigator, no data will be accumulated; with misdirection of it,
the plan of the experiment may be disregarded, the measurements made in error,
and the data misinterpreted. If an investigator becomes prematurely convinced
of the value of the method of treatment under study, random sampling of his
clinical material becomes increasingly onerous and distasteful, because his every
impulse as a good physician is against the denial to any patient of a method of
treatment which he believes to be effective. In addition, his enthusiasm may act
as an extraordinarily effective method of psychotherapy.
(5) Lack of adequate clinical material. The importance of this factor is obvious,
but we have several times fallen into the discouraging error of attempting a
planned clinical investigation without sufficient prospect of collecting enough
data to permit conclusions. Under very unusual conditions, study of a single
patient may permit conclusions as to the value of a particular method of treat-
ment, but this is rare.
(6) Certain corollary factors. (a) Lack of support. Few departments of derma-
tology have anything approaching adequate support for planned clinical experi-
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ments. It has been our experience that clinical investigations undertaken simply
as a part of a routine clinic or office practice, without provision for assignment of
special facilities and personnel, rarely adhere to plan. In any study involving
more than a few patients, it has been our policy not to undertake it unless the
facilities are the equivalent of one full-time person assigned to the project, and
it is believed that grantors would be well-advised to think of support of serious
clinical investigation in such terms.
(b) Pressure from grantors. One of the most exquisite forms of torture for
scientists is the habit of some granting agencies, government, foundational, and
pharmaceutical alike, to make specific grants for investigational projects for a
term of one year, with continuance of the grant dependent upon the prompt
elaboration of significant data, and with too frequently an unwritten provision
that such data must permit positive conclusions as to the effectiveness of a par-
ticular method of treatment. This has been a source of erroneous conclusions
and premature publication.
The above list is incomplete and in many respects superficial in its approach.
Reference is again made to more extended and fundamental expositions of the
requirements of a properly designed experiment and the judgment of evidence
obtained therefrom.
In spite of the difficulties of planned experiments in dermatology, as outlined
above, numerous papers of value are steadily appearing, and one is impressed
with the genuine progress which has been made in clinical investigation in this
field during the recent years. However, many examples may be cited of methods
of treatment which have no apparent sound foundation, and which may have
potentialities for harm, e.g., the following.
(1) Treatment of chronic discoid lupus erythematosus. Since the basic etiology
of this disease is poorly understood, it is not surprising that no adequate method
of treatment has been devised, with the possible exception of ACTH and Corti-
sone. It is well-established that some types of therapy are frequently harmful,
e.g., ultra-violet rays, but other methods of treatment are frequently used, have
demonstrable potentialities for harm, and are subjects of dispute as to efficacy.
These include injection of gold salts, of bismuth, and of arsenicals. There has
apparently been no planned study of the treatment of this disease.
(2) Other methods of treatment which have been in common use for years,
concerning which there are no reports based on planned experiments from which
conclusions may be drawn, include: (a) autohemotherapy in the treatment of
dermatitis presumed to have an allergic basis, or of psoriasis, (b) calcium salts by
injection or by mouth. These are non-toxic methods of treatment, and probably
have significant psychotherapeutic effects. There are, however, no data to indi-
cate conclusively that either of them by themselves may be the cause of improve-
ment of the eruption under treatment.
(3) The treatment of acne. Mention has previously been made of the profound
influence of the associated agent of time in judging the effectiveness of any par-
ticular method of treatment of this disease. Bloch (4) has collected accurate and
detailed information as to the incidence of acne, the time of onset, and the differ-
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ence in incidence and severity between the sexes. There is, however, no compar-
able accurate information as to the time of spontaneous involution of acne, and
the percentage of cases in which it occurs. It is quite probable that no such data
will ever be collected. Nevertheless, it seems worth while to point out that many
methods of treatment have been advised, and an attempt at evaluation made,
without consideration of the associated agent of passage of time. With methods of
treatment capable of producing serious side effects, such as x-ray therapy, the
administration of arsenic, or injection of hormones, it is essential that data based
on planned experiments be available. In the case of x-ray therapy, a study was
carried out some years ago in which only one side of the face of patients with
acne received x-ray therapy (5), and in relatively small series of patients treated,
no significant difference in the progress of the acne on each side of the face could
be detected in 19 of the 40 patients treated. Such a study might profitably be
extended.
(4) The treatment of warts. Ordinary warts present an outstanding example of a
disease of the skin due to a specific agent, a virus, in which psychotherapy has
been demonstrated to have a profound effect. (6) It is obvious, therefore, that in
the study of any particular method of treatment of warts, the associated agent of
psychogenic influence is always operative to a greater or less degree. The subject
of the treatment of warts has been the subject of a large number of papers in the
medical literature, and among them very few in which the possible effects of
agents other than treatment used have been considered.
As an example of the extent to which the requirements of a planned study have
been observed or disregarded in the treatment of warts, a leading specialty
journal (The Archives of Dermatology and Syphilology) has been reviewed for
the period 1920 to 1948, and all reports dealing with the treatment of verrucae
abstracted and subjected to analysis. It must be kept in mind that many of these
papers were simply a report of a sequence of events, and the authors did not
intend that sweeping conclusions should be drawn therefrom.
During this period of 28 years, 21 papers on the treatment of warts were pub-
lished in the journal reviewed. The treatment of 2505 patients with warts was
recorded in 16 of the papers, in five reports the number of patients treated was
not stated. The reports appeared rather evenly over the 28-year period, indicat-
ing a steady sustained interest in the problem, and inferring the absence of any
completely satisfactory method of treatment. In only two reports was the method
of treatment compared in effectiveness with a control series of untreated patients
or in a group receiving placebo therapy. In only one paper was the number of
"controls" adequate. It is of interest that in both the papers where controls were
included, as good or better results were obtained with placebo therapy as with
the particular medication under study. In one study, "100%" cures of warts were
reported as a "result" of intramuscular injections of bismuth subsalicylate. In
another paper published 7 years later, 50% cures were reported after treatment
with bismuth subsalicylate, but a cure resulted in 75% of patients with intra-
muscular injections of saline solution. Several papers reporting cures of warts in
almost 100% of cases by the injection of sulfarsphenamine preceded publication
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of the excellent paper by Allington (7) in which 52% of 105 patients with warts
were cured by injections of sulfarsphenamine, and 48% of 120 patients by injec-
tions of colored saline solution. This is one of the best examples of a planned
clinical study in the dermatologic medical literature.
A similar pattern of initial enthusiasm toward a particular method of treatment
is seen in the treatment of verrucae by the method of injection of an autolysate of
verrucous material. In the initial report of this method of treatment, 84% of the
patients are recorded as cured. In another report, in which the effect of injections
of a suspension of verrucous material was recorded, 17% successful results were
obtained. In the latter paper, the writer states that the probable effectiveness of
the method of treatment used was deprecated to the patients under treatment.
In another paper, in which a local injection of 50% urea solution was used on the
wart, the observer reported that 91% of his own cases were cured, but that when
he induced other physicians to try the same method of treatment, the incidence
of cure was some 50%.
It is readily apparent from this review of studies of various methods of treat-
ment of a single skin disease of known etiology, that many associated agents are
operative, including time, the site of the lesion, trauma, psychogenic influences,
and possible factors as yet unsuspected.
(5) X-ray therapy of inflammatory diseases affecting the skin. The discussion of
this modality of treatment will be restricted to its use for inflammatory diseases
of the skin due to exogenous and endogenous allergens, for the results of scratch-
ing, for bacterial infections of acute and chronic nature, and for superficial
mycotic infections (excluding ringworm of the scalp).
Since excessive x-ray therapy of any tissue is destructive in its action, and since
numerous instances of harmful sequellae on the skin are being seen, it seems ad-
visable to examine our present knowledge of x-ray therapy of acute and chronic
inflammatory eruptions of the skin, and subject the tremendous accumulated
experience to scrutiny. It is believed that the following principal conclusions
may be drawn:
1. There is an enormous and impressive weight of clinical evidence to indicate
that following the administration of superficial x-ray therapy to the skin for
various inflammatory conditions, many such patients show improvement and
some progress to apparent cure. However, some get worse, and the effect of such
treatment is often temporary.
2. No planned experiments, to our knowledge, have been carried out with
x-ray therapy of inflammatory dermatologic conditions, to determine what pro-
portion of the observed results might be caused by x-ray alone, and what propor-
tion to associated agents such as local therapy, the passage of time, changes in
environment, and psychogenic influences.
3. Under conditions in which x-ray therapy for such disease was not available
to large numbers of dermatologic patients, e.g., over-seas service in the Armed
Forces, one of us (DMP) could detect no significant difference in the numbers of
patients who progressed to prolonged dermatologic disability without x-ray
therapy, as compared to that noted under conditions of easy availability of such
therapy.
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4. The precise biologic effect of a few small doses of x-ray given at intervals of
5 to 7 days to the human skin remains to be determined. The mechanisms which
have been advanced to explain the action of x-ray on acute inflammatory proc-
esses may be regarded as somewhat hypothetical insofar as they furnish an
explanation for the involution of a dermatitis or eczema after a few fractional
x-ray exposures. These mechanisms, some of which have a sound experimental
background (8) include destruction of a proportion of the infiltrating lympho-
cytes and leucocytes, with "immediate consequence. . . that the antibodies,
ferments and other protective substances elaborated in these cells are liberated
and made more readily available for defensive purposes", secondary increase in
phagocytosis, or an inhibitory action on karyokinesis, or mitotic retardation in
the basal cell layer, or formation of antibodies within the tissue, or direct effects
upon hyperplastic vascular tissue. Regardless of proof or disproof that one or all
of these phenomena occur after the administration of a few small doses of x-ray,
it does not necessarily follow that x-ray of and by itself is the principal cause of
the involution of the inflammatory eruption under treatment.
On the basis of these considerations, it is believed that planned experiments
to determine the role of x-ray in causing involution of an inflammatory disease of
the skin are needed. This seems particularly urgent in the study of the effects of
x-ray tubes having very low inherent filtrations and capable of emitting waves of
varying types, with potential effects on the skin and other tissues which are as
yet incompletely known.
It is hoped that these examples of methods of treatment in which some doubt
may exist as to their causal role in the production of a desired clinical effect, con-
stitute sufficient argument for the need of planned clinical investigative experi-
ments in dermatology. It seems particularly advisable that such experiments
be carried out adequately in the case of methods of treatment which may have
immediate deleterious effects, such as sensitization, or late effects such as may
occur after x-ray therapy. The following studies which have been carried out in
the Department of Dermatology of the University of Pennsylvania are cited, as
examples of effects which may be caused by associated agents, in part to demon-
strate that useful information may result therefrom, and in part to indicate that
conclusive data from clinical experiments are often difficult to obtain. The first
study in a long-term one; the other two are minor studies conducted recently.
Example 1. The treatment of tinea capitis. For the past decade, Livingood,
Pillsbury, Newcomer, Kligman, and others in our clinic have been studying the
effect of local treatment in this disease, under conditions of adequate facilities
for the determination of the causative fungus, sufficient personnel for frequent
observation of the patients, and followup facilities sufficient to insure prolonged
observation of over 90% of the patients seen. The predominance of patients in
whom the causative fungus was M. audouini has permitted study of several
hundred patients with this disease. Livingood and Pillsbury (9) found that be-
tween 30% and 35% of patients with tinea capitis due to M. audouini progressed
to cure with no treatment, or with irregularly applied indifferent treatment.
This tendency of some patients to progress toward cure was not related to pu-
berty, or to other determinable factors. Such spontaneous cure required at least
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two months, and in many instances the period elapsing until spontaneous im-
provement was noted was much longer, too long to be of practical value or to
satisfy reasonable public health requirements to prevent spread of the disease.
It was clear, however, that the factor of time was an important associated agent
in the cure of M. audouini tinea capitis. This was not in accord with previous
concepts of the curability of this type of infection. The question has received
continued re-examination in our clinic by Scully et al. (11), Newcomer et al.
(12), and by [cligman (13), with complete affirmation that at least one-third of
patients with M. audouini infection progress toward spontaneous cure in vary-
ing periods of time, and that such a result may be predicted on the basis of slight
to severe perifollicular inflammatory response. It is becoming apparent that local
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therapeutic agents act not so much through the direct fungicidal action of chemi-
cals contained therein, but rather through their capacity to promote the local
immune response.
Example . Localantibacterial agents. In the treatment of superficial pyodermas
a study of the effectiveness of an ointment containing dihydroxy-hexachloro-
diphenyl-methane (hereinafter referred to as Gil), in the treatment of super-
ficial pyodermas in children has recently been completed (14). This compound
has been shown to have marked bactericidal action in vitro, and is effective in
reducing the number of bacteria on the surface of the normal human skin (14).
Neither of these actions gave assurance, however, that the compound in question
would be effective in the treatment of superficial bacterial infections of the skin,
and a clinical trial was undertaken.' One hundred eight children with various
types of superficial pyodermic processes were treated by a routine which in-
cluded thorough washing of the affected skin with soap and water once daily,
1 This study was supported by a grant froni the Givaudan-Delawanna corporation.
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and application of an ointment containing 2% Gil in a hydrophilic ointment
base (Aquaphor) twice daily. A "control" series of 46 patients with similar in-
fections were treated by a routine which included washing with soap and water
once daily, and application of the hydrophilic ointment without Gil twice daily.
The objective measurement used was apparent cure of the infection at the end of
seven days of treatment. Eighty-nine per cent of the soap and water-Gil treated
group were apparently well at that time, while 80% of the soap and water-
Aquaphor group were well.
Examination of the data indicated that almost all failures occurred in children
in whom the directions as to thorough washing of the skin had not been followed.
It seemed justified to conclude that in these patients with superficial bacterial
infections, the daily thorough use of soap and water, the application of a hydro-
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philic ointment, and the passage of time variously acted to bring about cure of
the disease, and that the use of a hydrophilic ointment containing 2% Gil made
a relatively insignificant contribution to this end (15).
Example 3. The local application of anti-histaminics. The introduction of com-
pounds having an anti-histamine effect has been of great value in the treatment
of allergic diseases affecting the skin. It is now apparent that the principal use-
fulness of these compounds when administered by mouth is in the treatment of
urticaria, and in some other diseases having an allergic component.
Several studies of the effect of antihistaminic compounds applied locally have
been reported (16a—h). In most of them, the interpretation of results have been
the relief of itching, a measurement in which each individual patient is the arbiter
of improvement. In a series of patients in which the comparative effectiveness of
an ointment base, and ointment base plus 2% Benadryl, Perry (17) could detect
no significant difference in the control of itching and in objective evidence of
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healing of the eruption in a series of patients with various inflammatory diseases
of the skin.
Following the report of usefulness of Thephorin in controlling itching by local
application to the skin, Baldridge (18) undertook a study in which the compara-
tive effectiveness of ointment base and ointment base plus 5% Thephorin was
determined in a series of patients with circumscribed neurodermatitis, atopic
dermatitis, pruritus ani and other miscellaneous pruritic eruptions. The oint-
ments used were of similar appearance, and the composition was unknown to the
patient. In patients with bilateral eruptions, the effectiveness of the two oint-
ments was compared on the two sides of the body. When this was not possible,
the ointments were changed without the knowledge of the patient, and the report
of antipruritic effect compared. The same individual observed the patients
throughout, and he was aware of the composition of the ointments dispensed,
which is undesirable. The comparative results are given in Fig. 3. It will be noted
that when an ointment base, either Carbowax or vanishing-type, was used, the
over-all relief of itching was estimated at 49%; when similar ointment bases con-
taining 5% Thephorin were used, the incidence of relief of itching was estimated
at 47%.
The plan of this experiment was admittedly not ideal. Further study, in which
objective improvement of the eruption, determination of the effect of the asso-
ciated agent of time, and dispensing of the medication and observation of the
results by a physician to whom the nature of the ointments was unknown, were
contemplated. However, the observation of several patients with convincing
evidence of acquired sensitivity to Thephorin rendered the experiment less
attractive, and it has been discontinued.
SUMMARY
1. The importance of accurate determination of the role of new methods
of dermatologic treatment as the causeofsubsequent changes in the course of a skin
disease is emphasized.
2. Thebasic requirements of a clinical experiment designed to yield data which
will permit conclusions are outlined. Some of the difficulties encountered in
planning and pursuing clinical investigative problems in dermatology are listed.
3. Certain examples of standard methods of dermatologic treatment which
have received acceptance and are in common use on the basis of uncontrolled
clinical observations are cited. It is emphasized that, particularly in methods of
treatment capable of producing harm, investigators have a grave responsibility
to determine to what extent the clinical result observed was caused by the treat-
ment used, and to what extent by associated agents or through chance.
4. Three examples of clinical studies in which associated agents played an
important role in the production of the clinical effect, and in which disregard of
these agents would have made a conclusion impossible, are cited.
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DISCUSSION
DR. MARION B. SULZBERGER: I am sure that all of us are grateful to Dr. Pills-
bury for putting this series of basic problems so clearly. First, he has shown that
we physicians must never look askance at proper clinical research. Most of us
here are physicians, and we must not forget that the result of clinical research is
the decisive step; and that, for dermatology, clinical research on the human skin
is the acid test, not research on the skin of the laboratory animal, even if he be an
anthropoid ape. If pharmacologists and toxicologists had tested penicillin for
toxicity in guinea pigs after Fleming had observed its effects on pathogenic mirco-
organisms in the test tube, they would most likely have killed all the guinea pigs
and we should never have gotten penicillin for human use. I have always been
convinced that in all fields of medicine clinical assays on the human being repre-
sent the sole reliable and final measure of the value or danger of measures and
remedies for human use.
Therefore, for 25 years I have tried to do, and to induce others to do, what
Dr. Pillsbury has outlined—sometimes with success and sometimes failure. In
evaluating externally applied remedies we have been using the "paired compari-
son method", thus, as best we could, overcoming the inherent difficulties regard-
ing evaluation of therapeutic measures on the skin, with the many uncontrollable
and varying factors which Dr. Pillsbury has mentioned. In many of our studies
we have been able to use different remedies comparatively and simultaneously
on similar lesions, symmetrically situated in the same individual—and such
comparisons have been the basis for much of our group's therapeutic studies.
Good examples are our recent clinical pilot studies with the fatty acids, against
fungous infections, with results which have been borne out completely by later
large scale clinical use.
Among older studies I can mention those of the late Dr. Henry Niles, of the
New York Skin and Cancer Unit, who carried out a series of experiments on the
"half-face" treatment of acne, one side irradiated with x-ray and the other side
with a placebo. Then also, the excellent study of Dr. Allington, who, at my sug-
gestion, carried out a series of treatments of warts by injections of sulfarsphena-
mine and another by injections of a placebo solution, exactly colored and made
to simulate the arsphenamine. Dr. Allington did not know what the material was
which he injected in each case. The solutions were prepared and the records kept
by a nurse and the doctor did not know which of his patients was getting the
colored placebo solution and which the arsphenamine, until the experiment was
completed. In both series the results were identical, and mostly good.
I might add, that in consonance with Dr. Pillsbury's ideas, we have at the
New York Skin and Cancer Unit a subdivision which has the task of treating
all patients who are not treated in other subdivisions by special modalities; anti-
mycotic, immunologic, surgical, x-ray, other physical therapy, etc. All other
patients come to a certain unit, which, carries out routine therapy and evalu-
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ates therapy. Formerly this Unit was called the "Old Case Room" and neither
patients, nor staff members nor students wanted to go there. Now we have
changed the name of that division to "Treatment Unit" and under the able
guidance of Dr. Frances Pascher it has been engaged in therapeutic assays and
standardization of methods for evaluating new and old forms of therapy. In a
few years it has thus become one of the most valuable of our teaching and in-
vestigative units, whose work is much sought after by students and staff and
welcomed by grateful patients.
Dn. CONRAD STRITZLER: As Dr. Pillsbury suggested, the evaluation of anti-
pruritics is a hazardous and difficult procedure. In line with Dr. Sulzberger's
suggestion, we have been using the method of paired symmetrical comparisons
in the evaluation of Thephorin ointment.
A group of patients with symmetrical pruritic lesions were treated by applying
the Thephorin ointment to one side, and the placebo control to the other. As the
slides indicate, the Thephorin treated side quite regularly showed improvement,
whereas the side to which the placebo was applied did not. I feel this approach is
a much more objective one than simply asking the patient which preparations
gave them more relief.
